ERYTECH provides financial update for Q2 2013 Post author:admERY Post published:July 18, 2013 Post category:Newsroom ERYTECH announced today its cash position and its revenues for the second quarter of 2013. You Might Also Like ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent April 25, 2022 ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update May 2, 2019 ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019
ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent April 25, 2022
ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019
